| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1036058799 |
| P356 | DOI | 10.1007/BF02256058 |
| P698 | PubMed publication ID | 12595759 |
| P2093 | author name string | Kevin R McIntosh | |
| Mark A Moorman | |||
| Manas K Majumdar | |||
| Diana Buyaner | |||
| Joseph D Mosca | |||
| Michele Keane-Moore | |||
| Wayne B Hardy | |||
| P2860 | cites work | The extracellular matrix as a cell survival factor | Q40241699 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 228-241 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Journal of Biomedical Science | Q15759332 |
| P1476 | title | Characterization and functionality of cell surface molecules on human mesenchymal stem cells | |
| P478 | volume | 10 |
| Q48742436 | A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration. |
| Q92493801 | A Microcavity Array-Based 4D Cell Culture Platform |
| Q43026554 | A comprehensive study on optimization of proliferation and differentiation potency of bone marrow derived mesenchymal stem cells under prolonged culture condition |
| Q34919711 | A prospective study of bone marrow hematopoietic and mesenchymal stem cells in type 1 Gaucher disease patients |
| Q37255056 | Activation of human mesenchymal stem cells impacts their therapeutic abilities in lung injury by increasing interleukin (IL)-10 and IL-1RN levels |
| Q37406683 | Adipose mesenchymal stromal cell function is not affected by methotrexate and azathioprine |
| Q79368670 | Administration of donor-derived mesenchymal stem cells can prolong the survival of rat cardiac allograft |
| Q39035161 | Adoptive cell transfer in autoimmune hepatitis |
| Q41906508 | Advances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy |
| Q42545530 | Allogeneic cell therapy: a new paradigm in therapeutics. |
| Q37404294 | Allogeneic murine mesenchymal stem cells: migration to inflamed joints in vivo and amelioration of collagen induced arthritis when transduced to express CTLA4Ig |
| Q37719559 | Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus |
| Q46924386 | Analysis of allogeneic and syngeneic bone marrow stromal cell graft survival in the spinal cord. |
| Q38072064 | Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment. |
| Q38289416 | Are stem cells a potential therapeutic tool in coeliac disease? |
| Q36235265 | Aspirin promotes bone marrow mesenchymal stem cell-based calvarial bone regeneration in mini swine |
| Q50956008 | Biological characteristics of human placental mesenchymal stem cells and their proliferative response to various cytokines. |
| Q38262146 | Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system. |
| Q34271229 | Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art |
| Q33432575 | Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis |
| Q39892342 | Bone marrow-derived stromal cells (BMSCs) interact with fibroblasts in accelerating wound healing |
| Q35842646 | Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential |
| Q37986552 | Cardiac cell therapy: boosting mesenchymal stem cells effects |
| Q24534652 | Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction |
| Q84617890 | Cell contact interaction between adipose-derived stromal cells and allo-activated T lymphocytes |
| Q90733799 | Cell membrane and bioactive factors derived from mesenchymal stromal cells: Cell-free based therapy for inflammatory bowel diseases |
| Q47613637 | Cell membrane coated nanoparticles: next-generation therapeutics |
| Q39524013 | Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells |
| Q41199245 | Comparison of drug and cell-based delivery: engineered adult mesenchymal stem cells expressing soluble tumor necrosis factor receptor II prevent arthritis in mouse and rat animal models |
| Q36026788 | Comprehensive characterization of mesenchymal stem cells from human placenta and fetal membrane and their response to osteoactivin stimulation. |
| Q39186262 | Concise Review: MSC Adhesion Cascade-Insights into Homing and Transendothelial Migration. |
| Q35200156 | Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies |
| Q49160720 | Culture and characterisation of equine peripheral blood mesenchymal stromal cells |
| Q39647492 | Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells |
| Q64099565 | Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation |
| Q55052510 | Derivation and characterization of human fetal MSCs: an alternative cell source for large-scale production of cardioprotective microparticles. |
| Q36547230 | Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates. |
| Q46932499 | Differentiation and neurological benefit of the mesenchymal stem cells transplanted into the rat brain following intracerebral hemorrhage |
| Q50230276 | Differentiation of hepatocytes from induced pluripotent stem cells derived from human hair follicle mesenchymal stem cells |
| Q42669512 | Effects of bone marrow-derived mesenchymal stem cells engraftment on vascular endothelial cell growth factor in lung tissue and plasma at early stage of smoke inhalation injury |
| Q35653335 | Effects of insulin-like growth factor-1 on the properties of mesenchymal stem cells in vitro |
| Q36920724 | Emerging Concepts in Paracrine Mechanisms in Regenerative Cardiovascular Medicine and Biology |
| Q38744215 | Emerging drugs for the treatment of Primary Biliary Cholangitis |
| Q92604968 | Enrichment of CD146+ Adipose-Derived Stem Cells in Combination with Articular Cartilage Extracellular Matrix Scaffold Promotes Cartilage Regeneration |
| Q42962199 | EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells. |
| Q41922293 | Evaluation of a novel poly(amidoamine) with pendant aminobutyl group on the cellular properties of transfected bone marrow mesenchymal stem cells |
| Q30660529 | Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact. |
| Q50207127 | Functional and Phenotypic Alteration of Intrasplenic Lymphocytes Affected by Mesenchymal Stem Cells in a Murine Allosplenocyte Transfusion Model |
| Q36633325 | Genetic mismatch affects the immunosuppressive properties of mesenchymal stem cells in vitro and their ability to influence the course of collagen-induced arthritis |
| Q34147415 | Glioma-associated cancer-initiating cells induce immunosuppression |
| Q52876941 | Heterogeneity of Stem Cells: A Brief Overview. |
| Q39632527 | High-cell density-induced VCAM1 expression inhibits the migratory ability of mesenchymal stem cells. |
| Q26750318 | Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? |
| Q37867955 | Homing of Mesenchymal Stem Cells |
| Q33776557 | How stem cells speak with host immune cells in inflammatory brain diseases |
| Q64355146 | Human Mesenchymal Stem Cells Differentiation Regulated by Hydroxyapatite Content within Chitosan-Based Scaffolds under Perfusion Conditions |
| Q50472629 | Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. |
| Q34803950 | Human bone marrow-derived mesenchymal stem cells |
| Q60609895 | Human mesenchymal stem cells at the single-cell level: simultaneous seven-colour immunofluorescence |
| Q35458958 | Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system |
| Q24796682 | Identification of subpopulations with characteristics of mesenchymal progenitor cells from human osteoarthritic cartilage using triple staining for cell surface markers |
| Q53443562 | Identifying Biomarkers of Wharton's Jelly Mesenchymal Stromal Cells Using a Dynamic Metabolic Model: The Cell Passage Effect. |
| Q36456612 | Immune modulation by mesenchymal stem cells |
| Q36737033 | Immune response to stem cells and strategies to induce tolerance |
| Q28084829 | Immunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo? |
| Q37202800 | Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms |
| Q35166506 | Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells |
| Q35769026 | Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005 |
| Q36609696 | Immunoregulatory function of mesenchymal stem cells |
| Q79838800 | Immunosuppressive properties of cloned bone marrow mesenchymal stem cells |
| Q37242568 | Inflammatory bowel disease: Moving toward a stem cell-based therapy |
| Q33898626 | Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression |
| Q35091555 | Influence of murine mesenchymal stem cells on proliferation, phenotype, vitality, and cytotoxicity of murine cytokine-induced killer cells in coculture |
| Q24324389 | Integrin expression and integrin-mediated adhesion in vitro of human multipotent stromal cells (MSCs) to endothelial cells from various blood vessels |
| Q54325075 | Integrin α4 impacts on differential adhesion of preadipocytes and stem cells on synthetic polymers. |
| Q28083741 | Interactions between MSCs and immune cells: implications for bone healing |
| Q30415068 | Interferon gamma and T cells inhibit osteogenesis induced by allogeneic mesenchymal stromal cells |
| Q92713451 | Interleukin-1β Enhances Umbilical Cord Mesenchymal Stem Cell Adhesion Ability on Human Umbilical Vein Endothelial Cells via LFA-1/ICAM-1 Interaction |
| Q33823473 | Intra-myocardial delivery of mesenchymal stem cells ameliorates left ventricular and cardiomyocyte contractile dysfunction following myocardial infarction |
| Q52866935 | Isolation and Manufacture of Clinical-Grade Bone Marrow-Derived Human Mesenchymal Stromal Cells. |
| Q104799973 | Kindlin-3 Mutation in Mesenchymal Stem Cells Results in Enhanced Chondrogenesis |
| Q46307085 | Mammalian MSC from selected species: Features and applications |
| Q42103653 | Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: what do we know so far? |
| Q38014842 | Mechanisms of gravitational sensitivity of osteogenic precursor cells. |
| Q93020627 | Mechanisms utilized by feline adipose-derived mesenchymal stem cells to inhibit T lymphocyte proliferation |
| Q90056972 | Mesenchymal Stem Cells Beyond Regenerative Medicine |
| Q90411558 | Mesenchymal Stem Cells from Human Exfoliated Deciduous Teeth and the Orbicularis Oris Muscle: How Do They Behave When Exposed to a Proinflammatory Stimulus? |
| Q47146529 | Mesenchymal Stem Cells in Cardiology |
| Q37809081 | Mesenchymal Stem Cells: Mechanisms of Inflammation |
| Q26864580 | Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus |
| Q26746104 | Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality? |
| Q38210870 | Mesenchymal stem cell insights: prospects in cardiovascular therapy |
| Q38063350 | Mesenchymal stem cell insights: prospects in hematological transplantation |
| Q38206110 | Mesenchymal stem cell priming: fine-tuning adhesion and function |
| Q34294935 | Mesenchymal stem cell therapy and acute graft-versus-host disease: a review |
| Q37766238 | Mesenchymal stem cell therapy for chronic renal failure |
| Q35889077 | Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine |
| Q36404011 | Mesenchymal stem cells as a novel vaccine platform |
| Q21245658 | Mesenchymal stem cells avoid allogeneic rejection |
| Q37310677 | Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model |
| Q37000697 | Mesenchymal stem cells for vascular regeneration |
| Q37247846 | Mesenchymal stem cells in ex vivo cord blood expansion |
| Q38032086 | Mesenchymal stem cells in tumor development: emerging roles and concepts |
| Q38977465 | Mesenchymal stem cells moderate immune response of type 1 diabetes |
| Q38328472 | Mesenchymal stem cells transplantation for systemic lupus erythematosus |
| Q37094023 | Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy |
| Q26865070 | Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease |
| Q34234464 | Mesenchymal stromal cells: current understanding and clinical status |
| Q64257472 | Metabolism in Human Mesenchymal Stromal Cells: A Missing Link Between hMSC Biomanufacturing and Therapy? |
| Q35869005 | Microenvironmental changes during differentiation of mesenchymal stem cells towards chondrocytes. |
| Q37772403 | Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential |
| Q38650560 | Molecular Mechanisms of Immunomodulation Properties of Mesenchymal Stromal Cells: A New Insight into the Role of ICAM-1. |
| Q42408039 | Multipotent neurogenic fate of mesenchymal stem cell is determined by Cdk4-mediated hypophosphorylation of Smad-STAT3. |
| Q54543616 | Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease. |
| Q35843862 | Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response |
| Q39301259 | Optimization of the isolation and expansion method of human mediastinal-adipose tissue derived mesenchymal stem cells with virally inactivated GMP-grade platelet lysate |
| Q42026203 | Optimization strategies for electrospun silk fibroin tissue engineering scaffolds |
| Q64904675 | Pediatric Mesenchymal Stem Cells Exhibit Immunomodulatory Properties Toward Allogeneic T and B Cells Under Inflammatory Conditions. |
| Q37872600 | Phenotypic Characterization of Mesenchymal Stem Cells from Various Tissues. |
| Q34546544 | Phenotypic characterization, osteoblastic differentiation, and bone regeneration capacity of human embryonic stem cell-derived mesenchymal stem cells |
| Q33746577 | Placental mesenchymal stem cells of fetal and maternal origins demonstrate different therapeutic potentials |
| Q38239650 | Plasmacytoid dendritic cells: development, functions, and role in atherosclerotic inflammation |
| Q46304821 | Polarization of T Lymphocytes Is Regulated by Mesenchymal Stem Cells in NZBWF1 and BALB/c Mice |
| Q42174855 | Preparation of laminated poly(ε-caprolactone)-gelatin-hydroxyapatite nanocomposite scaffold bioengineered via compound techniques for bone substitution |
| Q33528988 | Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially |
| Q35195181 | Protective effect of bone marrow mesenchymal stem cells in intestinal barrier permeability after heterotopic intestinal transplantation |
| Q36127161 | Proteomic identification of glycosylphosphatidylinositol anchor-dependent membrane proteins elevated in breast carcinoma |
| Q38282065 | Rationale for the potential use of mesenchymal stromal cells in liver transplantation |
| Q38874116 | Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. |
| Q92235085 | Recent trends in cell membrane-cloaked nanoparticles for therapeutic applications |
| Q34576628 | Retracted: Novel Mechanism of Inhibition of Dendritic Cells Maturation by Mesenchymal Stem Cells via Interleukin-10 and the JAK1/STAT3 Signaling Pathway |
| Q37766134 | Review of stem cell-based therapy for the treatment of cardiovascular disease |
| Q38162434 | Review: mesenchymal stem cells and corneal reconstruction |
| Q38116454 | Role of mesenchymal stem cells in leukaemia: Dr. Jekyll or Mr. Hyde? |
| Q58545047 | Single-cell, high-throughput analysis of cell docking to vessel wall |
| Q51281349 | Stem Cell Membrane-Coated Nanogels for Highly Efficient In Vivo Tumor Targeted Drug Delivery. |
| Q26785527 | Stem Cells and Progenitor Cells for Tissue-Engineered Solutions to Congenital Heart Defects |
| Q36729785 | Stem cell myths |
| Q39850212 | Stem cell therapy for ischemic heart disease |
| Q36349552 | Stem cells in inflammatory demyelinating disorders: a dual role for immunosuppression and neuroprotection |
| Q28078600 | Stem/progenitor cells and obstructive sleep apnea syndrome - new insights for clinical applications |
| Q42441110 | Surface CD24 distinguishes between low differentiated and transit-amplifying cells in the basal layer of human prostate |
| Q34255259 | TNFα and IL-1β influence the differentiation and migration of murine MSCs independently of the NF-κB pathway |
| Q42287329 | Tailored integrin-extracellular matrix interactions to direct human mesenchymal stem cell differentiation |
| Q39299031 | The Role of Integrin α6 (CD49f) in Stem Cells: More than a Conserved Biomarker. |
| Q38175297 | The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells. |
| Q40071382 | The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. |
| Q33658078 | The promising potential of menstrual stem cells for antenatal diagnosis and cell therapy |
| Q36268038 | The role of recipient T cells in mesenchymal stem cell-based tissue regeneration |
| Q90213463 | The role of ultrasound in enhancing mesenchymal stromal cell-based therapies |
| Q28082685 | The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control |
| Q39679315 | The use of four-colour immunofluorescence techniques to identify mesenchymal stem cells |
| Q37412940 | The use of mesenchymal stem cells in tissue engineering: A global assessment |
| Q39154447 | The use of mesenchymal stromal cells in treatment of lung disorders. |
| Q37974210 | Therapeutic implications of mesenchymal stem cells in liver injury |
| Q55221537 | Three-Dimensional Graphene-RGD Peptide Nanoisland Composites That Enhance the Osteogenesis of Human Adipose-Derived Mesenchymal Stem Cells. |
| Q36530799 | Tissue-Related Hypoxia Attenuates Proinflammatory Effects of Allogeneic PBMCs on Adipose-Derived Stromal Cells In Vitro |
| Q38074155 | Tolerance induction strategies in vascularized composite allotransplantation: mixed chimerism and novel developments. |
| Q42221839 | Toll-like receptors as modulators of mesenchymal stem cells |
| Q42873919 | Toward biomimetic materials in bone regeneration: Functional behavior of mesenchymal stem cells on a broad spectrum of extracellular matrix components |
| Q38151018 | Tracking stem cells in tissue-engineered organs using magnetic nanoparticles |
| Q38691354 | Translation, but not transfection limits clinically relevant, exogenous mRNA based induction of alpha-4 integrin expression on human mesenchymal stem cells. |
| Q27003127 | Use of mesenchymal stem cells for therapy of cardiac disease |
| Q35835944 | β1 Integrins Mediate Attachment of Mesenchymal Stem Cells to Cartilage Lesions |
Search more.